![Christopher Missling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Missling
Geen lopende functies
Vermogen: 4 M $ op 30-06-2026
Profiel
Christopher U.
Missling worked at Anavex Life Sciences Corp.
from 2013 to 2026 as President, CEO, Secretary, and Director.
Previous roles include Chief Financial Officer at ImmunoGen, Inc., CFO and Senior Vice President-Strategic Operations at Curis, Inc., Head of Financial Planning at Aventis, Inc., and Head of Healthcare Investment Banking at Brimberg & Co. Education includes graduate and doctorate degrees from Ludwig-Maximilians-Universität München, an MBA from WHU-Otto Beisheim School of Management, and an MBA from Kellogg School of Management.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 06-01-2026 | 1.510.165 ( 1,63% ) | 4 M $ | 30-06-2026 |
Eerdere bekende functies van Christopher Missling
| Bedrijven | Functie | Einde |
|---|---|---|
| ANAVEX LIFE SCIENCES CORP. | Algemeen Directeur | 30-04-2026 |
Aventis, Inc.
 Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Corporate Officer/Principal | - |
Brimberg & Co.
 Brimberg & Co. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
| IMMUNOGEN, INC. | Financieel Directeur/CFO | - |
| CURIS, INC. | Financieel Directeur/CFO | - |
Opleiding van Christopher Missling
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
19
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Aventis, Inc.
Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Brimberg & Co.
Brimberg & Co. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WHU-Otto Beisheim School of Management
 WHU-Otto Beisheim School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anavex Life Sciences Corp.
 Anavex Life Sciences Corp. BiotechnologyHealth Technology Engages in the development of innovative drug compounds | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
